Search - tctmd.com

Displaying 781 - 800 of 1002

Sort: Relevancy | Date

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Industry News

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

August 07, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Industry News

Physicians Implant World's First ProMRI® Quadripolar CRT-D System to Treat

July 15, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

June 27, 2014

News Industry News

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

June 27, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Daily News

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Yael L. Maxwell

June 24, 2014

News Industry News

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

June 18, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Daily News

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

L.A. McKeown

May 13, 2014

News Industry News

Study Shows Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

May 09, 2014

News Industry News

Study Results Show Significant Overall Cost Savings with St. Jude Medical Quadripolar System

May 09, 2014

News Industry News

St. Jude Medical Continues Its Quadripolar Technology Leadership at HRS 2014

May 08, 2014

Advertisement

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

PARTNER Analyses Highlight Mortality Curves After TAVR

Physicians Implant World's First ProMRI® Quadripolar CRT-D System to Treat

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Study Shows CRT-D Devices with Medtronic AdaptivCRT(TM) Associated with Reduction of Costs of Atrial Fibrillation

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

Study Shows Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

Study Results Show Significant Overall Cost Savings with St. Jude Medical Quadripolar System

St. Jude Medical Continues Its Quadripolar Technology Leadership at HRS 2014

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content